{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-290679","form_type":"8-K","ticker":"TNGX","cik":"0001819133","company_name":"Tango Therapeutics, Inc.","filed_at":"2025-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.588215+00:00","generated_at":"2026-05-16T17:41:21.304582+00:00","sec_items":["1.01","1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Tango Therapeutics enters $100M ATM offering with Leerink, terminates Jefferies ATM program","bullets":["New $100M at-the-market common stock sales agreement with Leerink Partners as agent, dated Nov 21, 2025.","Agent commission of up to 3.0% of gross sales price per share sold under the agreement.","Prior $100M Jefferies ATM program terminated effective Nov 21, 2025, with no penalties.","Shares to be sold via at-the-market or negotiated transactions at company's discretion."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-290679","json":"https://secwatch.observer/filing/0001193125-25-290679.json","markdown":"https://secwatch.observer/filing/0001193125-25-290679.md","text":"https://secwatch.observer/filing/0001193125-25-290679.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819133/000119312525290679/0001193125-25-290679-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819133/000119312525290679/d921087d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T17:41:21.304582+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}